The comparison of Avicenna’s view and modern medicine about gout
Tārīkh-i pizishkī i.e., Medical History,
Vol. 6 No. 19 (1393),
3 February 2015
,
Page 91-109
https://doi.org/10.22037/mhj.v6i19.7550
Abstract
Gout is a common disease. Iranian traditional physician and on top of them Avicenna suggested various treatment method for gout. Avicenna believes that the most common cause of arthritis is gout. He classified gout by the causing agent to hot and cold dystemperament. Diagnosis is base on patient's condition, type and pattern of pain, joint swelling and dietary habits. Treatment is base on type of dystemperament of patients. Many methods of Avicenna for prevention and treatment of gout are similar with modern medicine. For example, dietary regimen and meat abstinence in conventional medicine are similar to Avicenna's recommendations in “Canon of Medicine”.
- gout, Avicenna, Iranian traditional medicine, modern medicine
How to Cite
References
ابنسینا،(1387 ش.)، قانون در طب(ترجمه عبدالرحمن شرفکندی)، (هشتجلدی)، ج 5، چاپ پنجم، تهران، انتشارات سروش.
خدادوست، م.، ناصری، م.، پناهی(2013)، پیشگیری و درمان بیماریهای مفاصل از دیدگاه طب سنّتی ایران. Medical History, 3(7), 35-55.
مجید نیمروزی، علیرضا صالحیزاده، ع.، حسین کیانی، هادی ایمانیه، م. و محمود نجابت(2010)، شعر تعلیمی در پزشکی سنّتی: مطالعه موردی ارجوزه پزشکی ابنسینا. Iranian Journal of Medical Ethics and History of Medicine, 4(1).
ناصری، م.، اقبالیان، ف.، غفاری، ف.، اصغری، م. و حیدری، ر. (2013)، استاد دکتر عبداللهخان احمدیه احیاگر طب سنّتی بالینی ایران. Medical History, 5(15), 53-73.
Bhala, N., Emberson, J., Merhi, A., Abramson, S., Arber, N., Baron, J.,... FitzGerald, G. (2013). Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet, 382(9894), 769-779.
Buckland, J. (2011). Crystal arthropathies: MSU crystals and osteoblasts: insight into bone erosion in gout... Nature reviews. Rheumatology
Changizi Ashtiyani, S., Golestanpour, A., Shamsi, M., Tabatabaei, S. M., & Ramazani, M. (2012). Rhazes' prescriptions in treatment of gout. Iran Red Crescent Med J, 14(2), 108-112.
Chen, L. X., & Schumacher, H. R. (2008). Gout: an evidence-based review. J Clin Rheumatol, 14(5 Suppl), S55-62. doi: 10.1097/RHU.0b013e3181896921
Choi, H. K. (2010). A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol, 22(2), 165-172. doi: 10.1097/BOR.0b013e328335ef38
Cocco, G., Chu, D. C., & Pandolfi, S. (2010). Colchicine in clinical medicine. A guide for internists. Eur J Intern Med, 21(6), 503-508. doi: 10.1016/j.ejim.2010.09.010
Davatchi, F., Jamshidi, A. R., Banihashemi, A. T., Gholami, J., Forouzanfar, M. H., Akhlaghi, M.,... Gharibdoost, F. (2008). WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol, 35(7), 1384.
Faridi, P., Abolhassanzadeh, Z., Zarshenas, M. M., & Mohagheghzadeh, A. (2012). Gout Remedies in Traditional Iranian Medicine (TIM). Journal of Research on History of Medicine, 1(4 Nov).
Gout: basic science and clinical practice. (2012). New York: Springer.
Harirforoosh, S., & Jamali, F. (2009). Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert opinion on drug safety, 8(6), 669-681.
Hoffmeister, C., Trevisan, G., Rossato, M. F., de Oliveira, S. M., Gomez, M. V., & Ferreira, J. (2011). Role of TRPV1 in nociception and edema induced by monosodium urate crystals in rats. Pain, 152(8), 1777-1788. doi: 10.1016/j.pain.2011.03.025
HUNT, J. M., McTIGUE, J. C., & EDWARDS, N. L. (2011). Diagnosis and Management of Gout in 2011. J Musculoskel Med, 28.
Kang, E. H., Lee, E. Y., Lee, Y. J., Song, Y. W., & Lee, E. B. (2008). Clinical features and risk factors of postsurgical gout. Ann Rheum Dis, 67(9), 1271-1275. doi: 10.1136/ard.2007.078683
Kemp, T. J., Hirose, C. B., Coughlin, M. J., & Otto, R. (2010). Treatment of chronic tophaceous gout with a wound vacuum-assisted device. Foot Ankle Int, 31(8), 729-731. doi: 10.3113/FAI.2010.0729
Longo, D. L., & Harrison, T. R. (2012). Harrison's principles of internal medicine (18th ed). New York; London: McGraw-Hill.
Murray, R. K. (2012). Harper's illustrated biochemistry (29th ed). New York, N.Y.; London: McGraw-Hill Medical.
Nejabat, M., Maleki, B., Nimrouzi, M., Mahbodi, A., & Salehi, A. (2012). Avicenna and cataracts: a new analysis of contributions to diagnosis and treatment from the canon. Iran Red Crescent Med J, 14(5), 265-270.
Nuki, G., & Simkin, P. A. (2006). A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther, 8 Suppl 1, S1. doi: 10.1186/ar1906
Petroni, D. (1972). [Therapy of gout]. Clin Ter, 62(5), 467-483.
Pillinger, M. H., Rosenthal, P., & Abeles, A. M. (2007). Hyperuricemia and gout: new insights into pathogenesis and treatment. Bull NYU Hosp Jt Dis, 65(3), 215-221.
Roubenoff, R., Klag, M. J., Mead, L. A., Liang, K. Y., Seidler, A. J., & Hochberg, M. C. (1991). Incidence and risk factors for gout in white men. JAMA, 266(21), 3004-3007.
Saigal, R., Chakraborty, A., Yadav, R. N., & Prashant, R. K. (2006). Partial HPRT deficiency (Kelley-Seegmiller syndrome). J Assoc Physicians India, 54, 49-52.
Terkeltaub, R. (2010). Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol, 6(1), 30-38. doi: 10.1038/nrrheum.2009.236
van Durme, C. M., Wechalekar, M. D., Buchbinder, R., Schlesinger, N., van der Heijde, D., & Landewé, R. (2012). Non‐steroidal anti‐inflammatory drugs for acute gout. The Cochrane Library.
Wang, M., Jiang, X., Wu, W., & Zhang, D. (2013). A meta-analysis of alcohol consumption and the risk of gout. Clinical rheumatology, 32(11), 1641-1648.
Zaka, R., & Williams, C. J. (2006). New developments in the epidemiology and genetics of gout. Curr Rheumatol Rep, 8(3), 215-223.
Zurek, M. (2006). [Pathogenesis, diagnostics and therapy of gout]. Vnitr Lek, 52(7-8), 736-741.
- Abstract Viewed: 1810 times
- PDF Downloaded: 17197 times